Locked nucleic acid as a novel class of therapeutic agents

RNA Biology

Volumn 6, Issue 3, 2009, Pages 321-323

  Veedu, Rakesh N ^a   Wengel, Jesper ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Antisense; Aptamers; LNA; miRNA; Oligonucleotides; RNA targeting; siRNA

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; APTAMER; COMPLEMENTARY RNA; LOCKED NUCLEIC ACID; MICRORNA; SMALL INTERFERING RNA;

BINDING AFFINITY; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; NUCLEIC ACID STRUCTURE; REVIEW; RNA INTERFERENCE;

EID: 67650486013     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.6.3.8807     Document Type: Review

References (36)

1. Vitravene study group. Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDS. Am J Ophthalmol 2002; 133:475-483 (Pubitemid 34258057)
2. Singh SK, Nielsen P, Koshkin AA, Wengel J. LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognition. Chem Commun 1998; 455-456 (Pubitemid 128675297)
3. Koshkin AA, Nielsen P, Meldgaard M, Rajwanshi VK, Singh SK, Wengel J. LNA (Locked Nucleic Acid): An RNA mimic forming exceedingly stable LNA:LNA duplexes. J Am Chem Soc 1998; 120:13252-13253 (Pubitemid 29024087)
4. Obika S, Nanbu D, Hari Y, Andoh J, Morio K, Doi T, Imanishi T. Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2′-O,4′-C-methyleneribonucleosides. Tetrahedron Lett 1998; 39:5401-5404 (Pubitemid 28295121)
5. Koshkin AA, Singh SK, Nielsen P, Rajwanshi VK, Kumar R, Meldgaard M, et al. LNA (Locked Nucleic Acids): Synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation and unprecedented nucleic acid recognition. Tetrahedron 1998; 54:3607-3630 (Pubitemid 28108183)
6. Wengel J. Synthesis of 3′-C- and 4′-C-branched oligodeoxynucleotides and the development of Locked Nucleic Acid (LNA). Acc Chem Res 1999; 32:301-310
7. Petersen M, Wengel J. LNA: a versatile tool for therapeutics and genomics. Trends Biotechnol 2003; 21:74-81. (Pubitemid 36165007)
8. Vester B, Wengel J. LNA (Locked Nucleic Acid): High-affinity targeting of complementary RNA and DNA. Biochemistry 2004; 43:13233-13241 (Pubitemid 39391124)
9. Jespen JS, Sørensen MD, Wengel J. Locked Nucleic Acid: A potent nucleic acid analog in therapeutics and biotechnology. Oligonucleotides 2004; 14:130-146
10. Obika S, Nanbu D, Hari Y, Morio K, In Y, Ishida T, Imanishi T. Synthesis of 2′-O,4′-Cmethyleneuridine and -cytidine. Novel bicyclic nucleosides having a fixed C3'-endo sugar puckering. Tetrahedron Lett 1997; 38:8735-8738
11. Petersen M, Bondensgaard K, Wengel J, Jacobsen JP. Locked Nucleic Acid (LNA) recognition of RNA: NMR solution structures of LNA:RNA hybrids. J Am Chem Soc 2002; 124:5974-5982
12. Nielsen KE, Rasmussen J, Kumar R, Wengel J, Jacobsen JP, Petersen M. NMR Studies of Fully Modified Locked Nucleic Acid (LNA) Hybrids: Solution structure of an LNA:RNA hybrid and characterization of an LNA:DNA hybrid. Bioconjugate Chem 2004; 15:449-457 (Pubitemid 38657849)
13. Kauppinen S, Vester B, Wengel J. Locked Nucleic Acid (LNA): High-affinity targeting of RNA for diagnostics and therapeutics. Drug Discovery Today: Technologies 2005; 2:287-290
14. ørum H and Wengel J. Locked nucleic acids (LNA): A promising molecular family for genefunction analysis and antisense drug development. Curr Opin Mol Ther 2001; 3:239-243
15. Jakobsen MR, Haasnoot J, Wengel J, Berkhout B, Kjems J. Efficient inhibition of HIV-1 expression by LNA modified antisense oligonucleotides and DNAzymes targeted to functionally selected binding sites. Retrovirology 2007; 26; 4:29. (Pubitemid 46767386)
16. Vester B, Lundberg LB, Sørensen MD, Babu BR, Douthwaite S, Wengel J. LNAzymes: Incorporation of LNA-type monomers into DNAzymes markedly increases RNA cleavage. J Am Chem Soc 2002; 124:13682-13683 (Pubitemid 35378975)
17. Jadhav VM, Scaria V, Maiti S. Antagomirzymes: Oligonucleotide enzymes that specifically silence MicroRNA function. Angew Chem Int Ed 2009; 48:2557-2560
18. Dorsett Y, Tuschl T. siRNAs: Applications in functional genomics and potential as therapeutics. Nature Rev 2004; 3:318-329 (Pubitemid 38499759)
19. Mook OR, Baas F, de Wissel MB, Fluiter K. Evaluation of locked nucleic acid-modified small interfering RNA in vitro and in vivo. Mol Cancer Ther 2007; 6:833-843 (Pubitemid 46554553)
20. Bramsen JB, Laursen MB, Damgaard CK, Lena SW, Babu BR, Wengel J, Kjems J. Improved silencing properties using small internally segmented interfering RNAs. Nucleic Acids Res 2007; 35:5886-5897 (Pubitemid 47506303)
21. Ambros V. MicroRNAs: Tiny regulators with great potential. Cell 2001; 107:823-826 (Pubitemid 34084973)
22. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism and function. Cell 2004; 116:281-297 (Pubitemid 38167318)
23. Elmén J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S, et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008; 452:896-899 (Pubitemid 351550859)
24. Jayasena SD. Aptamers: An emerging class of molecules that rival antibodies in diagnostics. Clinical Chem 1999; 45:1628-1650 (Pubitemid 29419030)
25. Famulok M, Mayer G, Blind M. Nucleic acid aptamers-from selection in vitro to applications in vivo. Acc Chem Res 2000; 33:591-599
26. Nimjee SM, Christopher PR, Sullenger BA. Aptamers: An emerging class of therapeutics. Annu Rev Med 2005; 56:555-583
27. Darfeuille F, Hansen JB, ørum H, Di Primo C, Tolumé JJ. LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1. Nucleic Acids Res 2004; 32:3101-3107
28. Darfeuille F, Hansen JB, ørum H, Di Primo C, Tolumé JJ. Aptamers targeted to an RNA hairpin show improved specificity compared to that of complementary oligonucleotides. Biochemistry 2006; 45:12076-12082
29. Schmidt KS, Borkowski S, Kurreck J, Stephens AW, Bald R, Hecht M, et al. Application of locked nucleic acids to improve aptamer in vivo stability and targeting function. Nucleic Acids Res 2004; 32:5757-5765 (Pubitemid 39619159)
30. Lebars I, Richard T, Di Primo C, Tolumé JJ. LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1. Blood Cells Mol Dis 2007; 38:204-209
31. Di Primo C, Rudloff I, Reigadas S, Arzumanov A, Gait MJ, Tolumé JJ. Systematic screening of LNA/2′-O-methyl chimeric derivatives of a TAR RNA aptamer. FEBS Lett 2007; 771-774
32. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990; 346:818-822
33. Turek C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249:505-510 (Pubitemid 20248891)
34. http://www.santaris.com
35. Veedu RN, Vester B, Wengel J. Polymerase chain reaction and transcription using locked nucleic acid nucleotide triphosphates. J Am Chem Soc 2008; 130:8124-8125 (Pubitemid 351898512)
36. Veedu RN, Vester B, Wengel J. Efficient enzymatic synthesis of LNA-modified DNA duplexes using KOD DNA polymerase. Org Biomol Chem 2009; 7:1404-1409